Herpes zoster‐associated severity and duration of pain, health‐related quality of life, and healthcare utilization in Taiwan: a prospective observational study
- 10 September 2014
- journal article
- research article
- Published by Wiley in International Journal of Dermatology
- Vol. 54 (5) , 529-536
Abstract
Background: To assess the severity and duration of herpes zoster (HZ)‐associated pain (ZAP) and its impact on quality of life (QoL) and healthcare utilization (HCRU) from a patient perspective in routine care in Taiwan.Methods: A prospective, observational, single‐cohort study was conducted in five centers across Taiwan. Patients were recruited at different time points during their HZ episode and were followed for ≤180 days. ZAP was assessed with the Initial Zoster Impact Questionnaire and the Zoster Brief Pain Inventory, QoL with the EQ‐5D, and HCRU with a simple questionnaire.Results: A total of 150 patients were included with a mean age of 64.9 years and mean time since rash onset of 18.8 days. Prodromal pain was experienced by 64.7% of patients, of whom 91.8% reported moderate‐to‐severe pain. At enrollment, 98.0% of patients experienced ZAP. Mean ± SD worst pain score decreased from 5.95 ± 3.09 at enrollment to 2.65 ± 2.98 at 30 days and 0.28 ± 0.83 at 180 days. Postherpetic neuralgia was observed in 20.7% of patients. Mean ± SD EQ‐5D score significantly decreased (P < 0.001) from 0.91 ± 0.16 before rash onset to 0.67 ± 0.18 after rash onset, showing significant QoL deterioration up to 60 days. The impact of HZ on QoL and pain severity was similar across age groups. Significant HCRU was observed including visits to the doctor (83.3% of patients), specialist (30.7%), emergency department (24.7%), physiotherapist (23.3%), and hospitalizations (20.7%).Conclusion: Severe morbidity and significant HCRU are associated with HZ in Taiwan, supporting the need for early intervention and preventive strategies to reduce the HZ‐associated burden of illness.Keywords
This publication has 42 references indexed in Scilit:
- Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practicePain, 2012
- The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countriesJournal of Public Health, 2011
- The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective studyCanadian Medical Association Journal, 2010
- The impact of herpes zoster and post-herpetic neuralgia on quality-of-lifeBMC Medicine, 2010
- Vaccination against Herpes Zoster and Postherpetic NeuralgiaThe Journal of Infectious Diseases, 2008
- The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster VaccineThe Journal of Infectious Diseases, 2008
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of LifeClinical Infectious Diseases, 2004
- Postherpetic Neuralgia — Pathogenesis, Treatment, and PreventionNew England Journal of Medicine, 1996
- Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaireQuality of Life Research, 1993